SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nureca’s manufacturing arm completes annual registration with USFDA

14 Apr 2025 Evaluate

Nureca’s manufacturing subsidiary -- Nureca Technologies has successfully completed its annual registration with the United States Food and Drug Administration (USFDA). The company’s manufacturing facility in Mohali, Punjab is now officially listed. This registration authorizes Nureca Technologies to continue manufacturing and exporting a suite of medical devices to the United States, reinforcing the company’s commitment to quality, regulatory compliance, and global expansion. Nureca Technologies plays an important role in the design and manufacturing of smart, accessible, and consumer-focused devices under Nureca's flagship brands - Dr Trust, Dr Physio, and Trumom.  

The products that have been listed with the USFDA are Pad, Heating, Powered - Dr Trust; Bed, Flotation Therapy, Powered - Dr Trust; Stethoscope, Manual - Dr Trust; Massager, Therapeutic, Electric - Dr Physio; Dr Trust; Pump, Breast, Non-Powered - Dr Trust; Trumom. These medical devices are 510(k) exempt, classified as low-to-moderate risk by the FDA, and comply with all applicable quality system regulations and labelling requirements for the U.S. market.

Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs.

Nureca Ltd. Share Price

284.25 -5.05 (-1.75%)
11-May-2026 11:15 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 489.85
Poly Medicure 1645.15
Laxmi Denta 214.15
Nureca Ltd. 284.25
Hemant Surgical Inds 358.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×